United States

Almirall SA (ALM.MC)

ALM.MC on Madrid SE C.A.T.S.

23 Feb 2017
Change (% chg)

€-0.16 (-1.01%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Thu, Nov 24 2016

BRIEF-Almirall reaches agreement with employees for restructuring in Spain

* Says reaches agreement to implement restructuring plan in Spain, reduces to 102 from 121 a number of employees affected

BRIEF-Almirall reports 9-month net profit up 41 percent

* Reports 9-month EBITDA up 6.5 percent at 183.8 million euros ($203.4 million) versus 172.6 million euros year ago

BRIEF-Almirall presents restructuring plan affecting 121 jobs

* Presents restructuring plan in Spain affecting up to 121 jobs

BRIEF-Almirall announces data from pivotal phase-3 clinical trials with inhibitor to treat psoriasis

* Announces results from two pivotal phase-3 clinical trials (reSURFACE 1 and 2) achieving primary endpoint of Tildrakizumab, an investigational IL-23p19 inhibitor, in patients with moderate-to-severe plaque psoriasis Source text for Eikon:

BRIEF-Almirall announces positive phase III results for drug against psoriasis

* Announces positive results from the phase III trial showing efficacy of dimethyl fumarate, a new systemic oral drug for patients with chronic plaque psoriasis

Select another date:

More From Around the Web